Ep. 120 - Next-gen NK cells, Plus Woodcock & BMS’s Russian Withdrawal
BioCentury This Week
00:00
Is Bristol Myres Disengaged With Russia?
Bristol myres has not only said like the other companies, that it's not going to enroll new patients in clinical trials. The decision by b m s could affect patients in more than 50 trials and include everything from treatments for prostate, breast, renal and other cancers. A lot of people in russia and eastern europe, theire best way to access effective therapies is by participating in clinical trials so that's going to be impactble for them.
Transcript
Play full episode
